Global bioburden testing market expected to generate around USD 1,285 million by 2025, at a CAGR of around 12.1% between 2019 and 2025. Bioburden testing process involves measuring of viable microorganism on raw materials packaging and medical devices before sterilization.

Sarasota, FL -- (SBWire) -- 03/06/2019 --Zion Market Research has published a new report titled "Bioburden Testing Market by Product Type (Instrument and Consumables), by Test Type (Anaerobic, Aerobic, Spore, and Fungi), by Application (Sterility Testing, Medical Devices, and Raw Material), and by End-User (Biotechnology, Pharma, and CMO): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025". According to the report, the global bioburden testing market was valued at approximately USD 577 million in 2018 and is expected to generate around USD 1,285 million by 2025, at a CAGR of around 12.1% between 2019 and 2025.

Download Free PDF Research Report Brochure @ https://www.zionmarketresearch.com/requestbrochure/bioburden-testing-market

Bioburden testing process involves measuring of viable microorganism on raw materials packaging and medical devices before sterilization. This is an important step that helps in finalizing the various parameters for effective sterilization process to ensure safety and efficacy of the complete procedure. Bioburden testing is also known as microbial limit testing, which is witnessed across various industries, such as medical devices, pharmaceutical, etc., for quality control purpose. Bioburden tests are represented on the maximum colony forming unit and there are established guidelines for the same. This can be done via two different methods—Membrane-Filtration Method and Plate Count Method. Bioburden testing must be conducted carefully so as to not introduce any new microorganism to the sample or kill the existing organisms of the sample.

There are various major factors driving the global bioburden testing market over the forecast timeframe including the rapid expansion of the biopharmaceutical industry, increasing number of contract research organizations, and flourishing medical device industry. Moreover, the rising number of product recalls from the market due to microbial contamination is also expected to promote bioburden testing market expansion in the future. Furthermore, growing food and beverage safety concerns and supplements are expected to further drive the growth of bioburden testing market over the estimated timeframe. Huge spending on the R&D activities witnessed in the life sciences industry coupled with an increase in medical expenses and improvements made in the healthcare facilities are expected to create numerous growth opportunities in the market in the future. However, the escalating costs of laboratory equipment and the tedious procedure may obstruct the bioburden testing market evolution over the estimated time span.

The global bioburden testing market is classified into product type, application, test type, and end-user. On the basis of product type, the bioburden testing market is segmented into instrument and consumables. The consumables segment is anticipated to grow rapidly in the future. On the basis of test type, the bioburden testing market is segmented into anaerobic, aerobic, spore, and fungi. Based on application, the bioburden testing market is sectored into sterility testing, medical devices, and raw material. Based on end-user, the market is classified into biotechnology, pharma, and CMO. The CMO segment is expected to dominate the market over the forecast time period.

By region, North America is predicted to hold a major revenue share of the global bioburden testing market in the future. This can be attributed to the increasing use of bioburden tests by the biopharmaceutical and healthcare industries, massive support from the government for the establishment of well-developed pharmaceutical industry, and a growing number of research and development facilities. The Asia Pacific Bioburden testing market is anticipated to develop rapidly over the forecast time period owing to the presence of emerging economies, such as China and India.

Request Free Sample Report @ https://www.zionmarketresearch.com/sample/bioburden-testing-market

Some key players of the global bioburden testing market are SGS SA, NAMSA, Charles River, WuXi App Tec, bioMérieux S.A., Pacific BioLabs, Nelson Laboratories, LLC, Thermo Fisher Scientific, Becton, Dickinson and Company, and Merck KGaA, among others.

This report segments the global bioburden testing market as follows:

Global Bioburden Testing Market: Product Type Analysis

Instrument
Consumables

Global Bioburden Testing Market: Test Type Analysis

Anaerobic
Aerobic
Spore
Fungi

Global Bioburden Testing Market: Application Analysis

Sterility Testing
Medical Devices
Raw Material

Global Bioburden Testing Market: End-User Analysis

Biotechnology
Pharma
CMO

Inquiry more about this report @ https://www.zionmarketresearch.com/inquiry/bioburden-testing-market

Global Bioburden Testing Market: Regional Analysis

North America
U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa